Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 303 clinical trials
featured
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration- CEDAR STUDY

Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration- CEDAR STUDY

  • 1026 views
  • 23 Nov, 2020
  • 1 location
Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration

neovascularization (CNV) associated with age-related macular degeneration (AMD).

angiography
fluorescein angiography
photodynamic therapy
age-related macular degeneration
neovascularization
  • 38 views
  • 07 Nov, 2020
  • 1 location
OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)

A 2-year, phase 3, multicentre, randomised, parallel-group, sham-controlled, double-masked study. Primary efficacy will be determined at Week 52.

  • 0 views
  • 08 May, 2021
  • 24 locations
OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD)

A 2-year phase 3, multicentre, randomised, parallel-group, sham-controlled, double-masked study. Primary efficacy will be determined at Week 52.

  • 0 views
  • 09 May, 2021
  • 31 locations
Copaxone in Age Related Macular Degeneration

The purpose of the project is to investigate in eyes with dry AMD, the efficacy and safety as preventive therapy of the immunomodulatory substance named copaxone which had been proven as

blindness
age-related macular degeneration
  • 41 views
  • 07 Nov, 2020
  • 1 location
Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration

patients with neovascular age related macular degeneration.

bevacizumab
verteporfin
photodynamic therapy
corrected visual acuity
age-related macular degeneration
  • 14 views
  • 07 Nov, 2020
  • 1 location
Subretinal Macugen for Neovascular Age-Related Macular Degeneration

The purpose of this study is to assess the efficacy of pegaptanib (Macugen®) for neovascular (exudative) age-related macular degeneration (AMD) when the first dose is administered to the

angiography
fluorescein angiography
wet age-related macular degeneration
macugen
pegaptanib
  • 20 views
  • 07 Nov, 2020
  • 1 location
Connection Between Periodontitis and Exudative Age-related Macular Degeneration

as periodontitis, increase aqueous flare and possibly activates exudative age-related macular degeneration.

anti-infective
  • 20 views
  • 26 Jan, 2021
  • 1 location
Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration

The purpose of this study is to determine whether microplasmin given by intravitreal injection is effective and safe for the treatment of wet age-related macular degeneration (AMD) in

choroidal neovascular membrane
age-related macular degeneration
wet age-related macular degeneration
  • 32 views
  • 08 Nov, 2020
  • 1 location
TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration

The purpose of the study is to compare photodynamic therapy to transpupillary thermotherapy as a treatment method for choroidal neovascularization in age-related macular degeneration

angiography
fibrosis
macular degeneration
visual loss
photodynamic therapy
  • 19 views
  • 07 Nov, 2020
  • 1 location